Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.5%

2 terminated/withdrawn out of 21 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

1 of 14 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

7(50.0%)

Phase 4

3(21.4%)

Phase 1

3(21.4%)

Phase 2

1(7.1%)

14Total

N/A(7)

Phase 4(3)

Phase 1(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials

NCT03553420Recruiting

Registry for Patients With Lipodystrophy

Role: collaborator

NCT06452654Phase 4Recruiting

Anti-viral Action Against Type 1 Diabetes Autoimmunity

Role: collaborator

NCT04769037Not ApplicableActive Not Recruiting

Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity

Role: collaborator

NCT04234867Phase 1Terminated

Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)

Role: lead

NCT03815552Not ApplicableCompleted

Evaluation of the Eversense Continuous Glucose Monitoring System in Type I Diabetic Youth

Role: lead

NCT04427189Recruiting

Better Control in Pediatric and Adolescent diabeteS: Working to crEate CEnTers of Reference (SWEET- Registry)

Role: lead

NCT02914886Phase 4Completed

Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)

Role: lead

NCT02987738Phase 1Completed

Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes

Role: lead

NCT03364868Phase 2Completed

GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

Role: collaborator

NCT05118945Completed

Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update

Role: lead

NCT04507984Completed

Universal Familial Hypercholesterolemia Screening in Children

Role: collaborator

NCT03815487Not ApplicableCompleted

Comparison of Two Management Systems in Patients With Type 1 Diabetes (Pediatric SmartHome)

Role: lead

NCT02750527Completed

Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany

Role: lead

NCT03040414Not ApplicableCompleted

Fuzzy Logic Automated Insulin Regulation

Role: collaborator

NCT04814849Completed

Parents' Occupation After Diabetes Onset

Role: collaborator

NCT02636491Not ApplicableCompleted

Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D)

Role: lead

NCT02518022Not ApplicableWithdrawn

How to be Safe With Alcoholic Drinks in Diabetes

Role: lead

NCT02712580Not ApplicableUnknown

Therapeutic Effect of the Wireless Micro Current Stimulation in Pediatric Deep Dermal Burns and Scald Injuries

Role: lead

NCT02325193Completed

"MiniMed 640G System" User Evaluation With the Question of Reducing the Rate of Hypoglycemia

Role: lead

NCT02325206Phase 1Completed

Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes

Role: lead